Infants and young children are among hundreds of patients set to receive new life-saving drugs for rare blood cancers. Around 200 patients a year will benefit from the 2 new cutting-edge treatments approved by NHS England, offering fresh hope to families when other therapies have failed. Dabrafenib is a tablet that treats histiocytic neoplasms – […]
Read More on the NHS website.